Switch to Europe/Worldwide website Switch to German website Switch to French website Switch to OriGene Technologies, Inc. (North America)
Home » Target » MED1 antibody

MED1 antibody

(reset)

Principal name

MED1 antibody

Alternative names for MED1 antibody

ARC205, CRSP1, CRSP200, DRIP205, DRIP230, PBP, PPARBP, PPARGBP, RB18A, TRAP220, TRIP2, Mediator complex subunit 1, Peroxisome proliferator-activated receptor-binding protein, Thyroid hormone receptor-associated protein complex 220 kDa component, Thyroid receptor-interacting protein 2, p53 regulatory protein RB18A, Vitamin D receptor-interacting protein complex component DRIP205, Activator-recruited cofactor 205 kDa component

SwissProt ID

Q15648 (Human), Q6INP8 (Xenla), Q8VDQ7 (Mouse), Q925J9 (Mouse)

Gene ID

5469 (MED1), 19014 (Med1)

Ncbi ID

9606, NP_004765.2, NM_004774, NP_001073587.1, NM_134027, NM_001080118, NM_013634

Available reactivities

Hu (Human), Ms (Mouse), Mky (Monkey), Rt (Rat)

Available hosts

Mouse, Rabbit

Available applications

Enzyme Immunoassay (E), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB), Paraffin Sections (P), Immunoprecipitation (IP), ChIP assay (ChIP)

Background of MED1 antibody

In mammalian cells, transcription is regulated in part by high molecular weight coactivating complexes that mediate signaling between transcriptional activators and initiation factors. These complexes include the thyroid hormone receptor-associated protein (TRAP) complex, which interacts with thyroid receptors (TR), vitamin D receptors and other steroid receptors to facilitate hormone induced transcriptional activation. The TRAP complex consists of numerous proteins ranging in size from 20 to 240 kDa, including TRAP95, TRAP100, TRAP150, TRAP220 and TRAP230, that are characterized by the presence of a nuclear receptor recognition motif which mediates the liganddependent binding of TRAP proteins to the nuclear receptors. TRAP220 and TRAP100 are widely expressed and most abundantly detected in skeletal muscle, heart and placenta. TRAP95, TRAP150 and TRAP230 facilitate TR induced transcription by associating with an additional transcriptional coactivating complex SMCC (SRB and MED protein cofactor complex), which consists of various subunits that share homology with several components of the yeast transcriptional mediator complexes.

H00005469-M01 - MED1
Immunofluorescence of monoclonal antibody to PPARBP on HeLa cell . [antibody concentration 10 ug/ml]
H00005469-M01 - MED1
Western Blot analysis of PPARBP expression in transfected 293T cell line by PPARBP monoclonal antibody (M01), clone 2A2.Lane 1: PPARBP transfected lysate(61.6 KDa).Lane 2: Non-transfected lysate.
H00005469-M01 - MED1
Detection limit for recombinant GST tagged PPARBP is approximately 0.3ng/ml as a capture antibody.
H00005469-M02 - MED1
Detection limit for recombinant GST tagged PPARBP is approximately 0.1ng/ml as a capture antibody.
H00005469-M03 - MED1
Detection limit for recombinant GST tagged PPARBP is approximately 0.1ng/ml as a capture antibody.
H00005469-M04 - MED1
Detection limit for recombinant GST tagged PPARBP is approximately 0.1ng/ml as a capture antibody.
H00005469-M05 - MED1
Detection limit for recombinant GST tagged PPARBP is approximately 0.3ng/ml as a capture antibody.
H00005469-M06 - MED1
Detection limit for recombinant GST tagged PPARBP is approximately 0.03ng/ml as a capture antibody.
AP06737PU-N - MED1
Immunohistochemistry analysis of TRAP220 antibody (Cat.-No.: AP06737PU-N) in paraffin-embedded human breast carcinoma tissue.
AP06737PU-N - MED1
Western blot analysis of TRAP220 antibody (Cat.-No.: AP06737PU-N) in extracts from Jurkat cells.
A0556-1 - MED1
Immunohistochemistry analysis of paraffin-embedded human heart, using PPAR-BP (Phospho-Thr1457) Antibody. The picture on the right is treated with the synthesized peptide.
A0556-1 - MED1
Immunofluorescence analysis of HeLa cells, using PPAR-BP (Phospho-Thr1457) Antibody. The picture on the right is treated with the synthesized peptide.
A0556-1 - MED1
Western blot analysis of extracts from HuvEc cells treated with Serum 20% 30', using PPAR-BP (Phospho-Thr1457) Antibody. The lane on the right is treated with the synthesized peptide.
B0556-1 - MED1
Immunofluorescence analysis of HeLa cells, using PPAR-BP (Ab-1457) Antibody. The picture on the right is treated with the synthesized peptide.
C11093-1 - MED1
Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue, using MED1 Antibody. The picture on the right is treated with the synthesized peptide.
C11093-1 - MED1
Western blot analysis of extracts from Jurkat cells, using MED1 Antibody. The lane on the right is treated with the synthesized peptide.
CPA1917-100ul - MED1
Immunohistochemical analysis of TRAP220 staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
CPA1917-100ul - MED1
Immunofluorescent analysis of TRAP220 staining in HuvEc cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue).
CPA1917-100ul - MED1
Western blot analysis of TRAP220 expression in HeLa (A); HuvEc (B); Jurkat (C) whole cell lysates.
CPA4460-100ul - MED1
Western blot analysis of TRAP220 (pT1457) expression in Jurkat (A); HeLa (B); NIH3T3 (C) whole cell lysates.
CPA4460-100ul - MED1
Immunohistochemical analysis of TRAP220 (pT1457) staining in human colon cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugad compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
CPA4460-100ul - MED1
Immunofluorescent analysis of TRAP220 (pT1457) staining in Jurkat cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 deg C in a hidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue).
TA314366 - MED1
Western blot analysis of extracts from Jurkat cells, using MED1 antibody.The lane on the right is treated with the synthesized peptide.
TA314366 - MED1
Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue using MED1 antibody.The picture on the right is treated with the synthesized peptide.
TA325682 - MED1
Western blot analysis of PPAR-BP expression in HuvEc whole cell lysates,The lane on the left is treated with the antigen-specific peptide.

12 Item(s)

per page

Primary Antibodies

Catalog No. Host Iso. Clone Pres. React. Applications  

MED1 antibody
  Rabbit polyclonal anti-MED1 antibody  
Western blot analysis of extracts from Jurkat cells, using MED1 antibody.The lane on the right is treated with the synthesized peptide. Rabbit IgG Purified Hu, Ms E, P, WB
0.1 ml / €335.00
  OriGene Technologies, Inc.
+1 additional image

MED1 antibody
  Rabbit Polyclonal PPAR-BP Antibody  
Western blot analysis of PPAR-BP expression in HuvEc whole cell lysates,The lane on the left is treated with the antigen-specific peptide. Rabbit IgG Purified Hu, Ms WB
0.1 ml / €335.00
  OriGene Technologies, Inc.

MED1 antibody
Immunohistochemistry analysis of TRAP220 antibody (Cat.-No.: AP06737PU-N) in paraffin-embedded human breast carcinoma tissue. Rabbit Aff - Purified Hu, Ms P, WB
0.1 mg / €370.00
  OriGene Technologies GmbH
+1 additional image

Lysates

Catalog No.    

MED1 overexpression lysate
MED1 overexpression lysate  
0.1 mg / €495.00
  OriGene Technologies, Inc.

Human Lenti ORF Particles

Catalog No.    

Lenti ORF particles, MED1 (mGFP-tagged) - Human mediator complex subunit 1 (MED1), 200 uL, >10^7 TU/mL
Lenti ORF particles, MED1 (mGFP-tagged) - Human mediator complex subunit 1 (MED1), 200 uL, >10^7 TU/mL  
200 µl / €1,400.00
  OriGene Technologies, Inc.
 

Lenti ORF particles, MED1 (Myc-DDK tagged) - Human mediator complex subunit 1 (MED1) , 200 uL, >10^7 TU/mL
Lenti ORF particles, MED1 (Myc-DDK tagged) - Human mediator complex subunit 1 (MED1) , 200 uL, >10^7 TU/mL  
200 µl / €1,250.00
  OriGene Technologies, Inc.
 

Mouse Lenti ORF Particles

Catalog No.    

Lenti ORF particles, Med1 (GFP-tagged) - Mouse mediator complex subunit 1 (Med1), transcript variant 1, 200 uL, >10^7 TU/mL
Lenti ORF particles, Med1 (GFP-tagged) - Mouse mediator complex subunit 1 (Med1), transcript variant 1, 200 uL, >10^7 TU/mL  
200 µl / €2,660.00
  OriGene Technologies, Inc.
 

Lenti ORF particles, Med1 (GFP-tagged) - Mouse mediator complex subunit 1 (Med1), transcript variant 2, 200 uL, >10^7 TU/mL
Lenti ORF particles, Med1 (GFP-tagged) - Mouse mediator complex subunit 1 (Med1), transcript variant 2, 200 uL, >10^7 TU/mL  
200 µl / €1,260.00
  OriGene Technologies, Inc.
 

Lenti ORF particles, Med1 (GFP-tagged) - Mouse mediator complex subunit 1 (Med1), transcript variant 3, 200 uL, >10^7 TU/mL
Lenti ORF particles, Med1 (GFP-tagged) - Mouse mediator complex subunit 1 (Med1), transcript variant 3, 200 uL, >10^7 TU/mL  
200 µl / €2,700.00
  OriGene Technologies, Inc.
 

Lenti ORF particles, Med1 (Myc-DDK-tagged) - Mouse mediator complex subunit 1 (Med1), transcript variant 1, 200 uL, >10^7 TU/mL
Lenti ORF particles, Med1 (Myc-DDK-tagged) - Mouse mediator complex subunit 1 (Med1), transcript variant 1, 200 uL, >10^7 TU/mL  
200 µl / €2,410.00
  OriGene Technologies, Inc.
 

Lenti ORF particles, Med1 (Myc-DDK-tagged) - Mouse mediator complex subunit 1 (Med1), transcript variant 2, 200 uL, >10^7 TU/mL
Lenti ORF particles, Med1 (Myc-DDK-tagged) - Mouse mediator complex subunit 1 (Med1), transcript variant 2, 200 uL, >10^7 TU/mL  
200 µl / €1,140.00
  OriGene Technologies, Inc.
 

Lenti ORF particles, Med1 (Myc-DDK-tagged) - Mouse mediator complex subunit 1 (Med1), transcript variant 3, 200 uL, >10^7 TU/mL
Lenti ORF particles, Med1 (Myc-DDK-tagged) - Mouse mediator complex subunit 1 (Med1), transcript variant 3, 200 uL, >10^7 TU/mL  
200 µl / €2,430.00
  OriGene Technologies, Inc.
 

12 Item(s)

per page
12 products - FILTER YOUR RESULTS!

Available Filters

Product Type
  1. Human Lenti ORF Particle (2)
  2. Lysate (1)
  3. Mouse Lenti ORF Particle (6)
  4. Primary Antibody (3)
Clonality
  1. Polyclonal (3)
Target
  1. MED1 (3)
Reactivity
  1. Human (Hu) (3)
  2. Mouse (Ms) (3)
Applications
  1. Western blot / Immunoblot (WB) (3)
  2. Paraffin Sections (P) (2)
  3. Enzyme Immunoassay (E) (1)
Presentation
  1. Purified (2)
  2. Aff - Purified (1)
Host
  1. Rabbit (3)
Images
  1. 1 image (3)
Images: Applications
  1. Western blot / Immunoblot (WB) (3)
  2. IHC (1)
  3. Paraffin Sections (P) (1)
Manufacturer
  1. OriGene Technologies (12)
Service
  • OriGene Technologies GmbH
  • Schillerstraße 5
  • D-32052 Herford
  • Germany
  • phone: +49-5221-34606-0
  • free call: 0800-227 47 46 (Germany only)
  • fax: +49-5221-34606-11
  • email: info-de@origene.com
  • orders: ordering-de@origene.com
 
© Copyright 1998 - 2018 OriGene Technologies GmbH
  • LinkedIn